Clume Health review

The program determines the price

Clume Health lists its full-dose Signature program from $259 per month and its Microdose/Maintain program from $219. Each program offers semaglutide or tirzepatide, oral or injectable, at the same listed program price. That makes the actual clinical category important: the lower maintenance or microdose amount is not simply a discount on an identical Signature prescription. Ask the clinician which preparation is proposed and why, then obtain the supply and complete charge for that specific choice.

Lower advertised equivalents require longer prepayment: $186 on a 52-week Signature plan and $200 on a twelve-week Microdose/Maintain plan. Those terms should remain attached to the smaller figures. Ask for the actual amount collected and how the service defines its monthly equivalent within a week-based commitment. Do not assume that a 52-week total is twelve times a label without the agreement confirming the calculation. The full financial authorization matters more than a smaller number presented for comparison.

The homepage does not match the program menu

The homepage advertises weight-management programs starting at $199 and a molecular-optimization offer from $159, with asterisks that do not lead to an explanatory footnote. Those figures do not match the published program choices. Request a written explanation instead of treating either as a hidden cheaper GLP-1 plan. The molecular program also concerns products such as NAD+ and sermorelin, which are separate from the semaglutide and tirzepatide purchase under consideration.

A wide program menu can support a useful clinical conversation without making every offering appropriate or necessary. Keep any adjunct itemized with its own clinical rationale and charge. Likewise, equal prices for oral and injected forms do not establish equal evidence, interchangeable dosing, or identical administration instructions. Compounded oral preparations should not inherit an approved brand's labeling. A patient should receive a product-specific explanation rather than choose a route simply because the storefront makes the monthly amount the same.

The clinical layer and seller are identified

The legal material names North Atelier LLC doing business as Clume Health, while OpenLoop provides the clinical and prescribing layer. Clume also names four dispensing pharmacies. Those disclosures are useful for understanding responsibility, but confirm the actual practice, clinician, and licensed pharmacy location assigned to your prescription. A partner list does not establish that every order has the same concentration, ingredients, or instructions, and a shared pharmacy does not by itself prove common ownership with another brand.

The service does not publish a complete state list. Confirm eligibility where you will attend care and receive medication before starting an application. For a compounded product, request the formulation, quantity, storage, usable period, and written directions. Compounded medications are not FDA approved. A named clinical network or pharmacy improves accountability without transferring an approved brand's regulatory status to the finished preparation or establishing specialist expertise in every medical circumstance.

Seventy-two hours is the stopping deadline

Clume requires cancellation at least 72 hours before the next billing date to avoid that cycle's charge. Its policy states that the month of cancellation and prior months are not refunded. Those limits matter more when choosing a longer financial term, and the agreement should explain how they apply to an unused prepaid balance. Obtain the actual cancellation method and confirmation rather than rely only on the ability to contact customer support when another order is approaching.

Clume may interest someone who values named care partners and wants several forms under one program structure. The mismatched homepage figures and week-based prepayment need clarification before choosing on the lower equivalent. Its public material does not substantively address pregnancy, breastfeeding, postpartum timing, or PCOS, so relevant needs deserve direct discussion. Compare the actual program, full charge, prescription, accessible follow-up, and stopping terms together. Neither the equal molecule price nor a lower maintenance label should replace an individual clinical and financial assessment.